Rapid and Ultrasensitive CRISPR-SERS Biosensing of Circulating Tumor Cell mRNAs for Molecular Metastatic Risk Assessment

Metastatic recurrence remains a major cause of poor prognosis in hepatocellular carcinoma (HCC), yet sensitive molecular assessment of metastatic risk is still limited. Circulating tumor cell (CTC)-derived transcripts offer a direct readout of tumor dissemination programs, but their rapid multiplex analysis remains challenging because of low-input rare-cell samples, low transcript abundance, and handling-associated molecular loss. Here, we report the Flexible LAMP-assisted Raman-CRISPR Engine for CTC mRNA analysis (FLARE-CTC) for multiplex transcript profiling and molecular metastatic risk assessment in HCC. Built on a flexible hierarchical surface-enhanced Raman scattering interface fabricated by a reverse-assembly peel-off transfer process, FLARE-CTC integrated rapid isothermal amplification, CRISPR-Cas12a recognition, and single-stranded DNA linker-mediated Raman-active nanoprobes to establish an anchoring-to-release Raman readout. Following CTC enrichment and on-chip lysis, this design enabled parallel quantification of seven HCC CTC-associated transcripts and β-actin within 30 min at attomolar-level sensitivity. In 58 clinical samples, integrated HCC identity-related transcripts distinguished HCC patients from healthy controls with an AUC of 0.972. Further integration of epithelial-mesenchymal transition- and stemness-associated transcripts generated a metastasis score that assessed metastatic risk with an AUC of 0.892, sensitivity of 0.947, and specificity of 0.857. A two-dimensional risk map combining diagnostic and metastatic scores further visualized patient-level molecular heterogeneity and identified imaging-negative individuals with high-risk molecular profiles. Overall, FLARE-CTC provides a rapid, ultrasensitive, and scalable biosensing strategy for multiplex CTC mRNA analysis and molecular metastatic risk assessment in HCC.

Authors

Institutions

Publication Details

Journal
Analytical Chemistry
Published
2026-11-18
DOI
https://doi.org/10.1021/acs.analchem.6c06668
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rapid and Ultrasensitive CRISPR-SERS Biosensing of Circulating Tumor Cell mRNAs for Molecular Metastatic Risk Assessment

Xin Han, Jiaojiao Sun, Hao Li, Hong Zhu et al.
Analytical Chemistry
Advanced biosensing and bioanalysis techniques
article

Rapid and Ultrasensitive CRISPR-SERS Biosensing of Circulating Tumor Cell mRNAs for Molecular Metastatic Risk Assessment

Xin Han, Jiaojiao Sun, Hao Li, Hong Zhu, Rongrong Xia, Wei Li
article en

Abstract

Metastatic recurrence remains a major cause of poor prognosis in hepatocellular carcinoma (HCC), yet sensitive molecular assessment of metastatic risk is still limited. Circulating tumor cell (CTC)-derived transcripts offer a direct readout of tumor dissemination programs, but their rapid multiplex analysis remains challenging because of low-input rare-cell samples, low transcript abundance, and handling-associated molecular loss. Here, we report the Flexible LAMP-assisted Raman-CRISPR Engine for CTC mRNA analysis (FLARE-CTC) for multiplex transcript profiling and molecular metastatic risk assessment in HCC. Built on a flexible hierarchical surface-enhanced Raman scattering interface fabricated by a reverse-assembly peel-off transfer process, FLARE-CTC integrated rapid isothermal amplification, CRISPR-Cas12a recognition, and single-stranded DNA linker-mediated Raman-active nanoprobes to establish an anchoring-to-release Raman readout. Following CTC enrichment and on-chip lysis, this design enabled parallel quantification of seven HCC CTC-associated transcripts and β-actin within 30 min at attomolar-level sensitivity. In 58 clinical samples, integrated HCC identity-related transcripts distinguished HCC patients from healthy controls with an AUC of 0.972. Further integration of epithelial-mesenchymal transition- and stemness-associated transcripts generated a metastasis score that assessed metastatic risk with an AUC of 0.892, sensitivity of 0.947, and specificity of 0.857. A two-dimensional risk map combining diagnostic and metastatic scores further visualized patient-level molecular heterogeneity and identified imaging-negative individuals with high-risk molecular profiles. Overall, FLARE-CTC provides a rapid, ultrasensitive, and scalable biosensing strategy for multiplex CTC mRNA analysis and molecular metastatic risk assessment in HCC.

Analytical Chemistry
Nanjing University of Chinese Medicine (CN), Chinese Academy of Sciences (CN), Jinan Institute of Quantum Technology (CN), First Affiliated Hospital of Soochow University (CN), The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital) (CN)
National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Jiangsu Province, Natural Science Foundation of Shandong Province
Good health and well-being
Advanced biosensing and bioanalysis techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon